Ranchi News Desk

Dyspepsia Market 2019 Global Profit Growth, Sales Revenue, Emerging Technologies, Competitive Landscape, Top Key Players Study and Business Trends by Forecast 2023

 Breaking News
  • No posts were found

Dyspepsia Market 2019 Global Profit Growth, Sales Revenue, Emerging Technologies, Competitive Landscape, Top Key Players Study and Business Trends by Forecast 2023

September 21
08:24 2019
Dyspepsia Market 2019 Global Profit Growth, Sales Revenue, Emerging Technologies, Competitive Landscape, Top Key Players Study and Business Trends by Forecast 2023

Dyspepsia Market
Global Dyspepsia Market by Diagnosis ( Blood Tests, Breath Tests, Stool Tests ), Treatment (Antacids, Antibiotics, H2 Blockers, Proton Pump Inhibitors), End-User (Hospital, Clinic, Ambulatory Surgical Centre) – Global Forecast Till 2023

Market Insights

Dyspepsia is a chronic medical condition which causes discomfort in the upper abdomen as a result of indigestion. The stomach and the small intestine, and sometimes the esophagus does not function properly which is the main reason for the discomfort. Gastritis, peptic ulcers, gallstones, stomach cancer, constipation, reduced blood flow in the intestine are other causes for dyspepsia. Overeating, over-consumption of alcohol and smoking, might also cause dyspepsia. The global dyspepsia market is perceived to be a steadily growing market as per the analysis of market Research Future (MRFR).

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6351  

Surging prevalence of digestive diseases across the globe is one of the prime reasons for the growth of the global dyspepsia market. The Centers for Disease Control and Prevention estimated 14.7 Mn people in the US to be suffering from digestive ulcers in 2016. Also, the American Cancer Society projected 26,240 new cases of stomach cancer to be diagnosed in the year 2018. The rise in the global geriatric population remains a significant growth driver. The aged populace is generally more susceptible to digestive disorders and induces high demand for diagnosis & treatment. Other factors boosting the growth of the market include the growing occurrence of diabetes and thyroid among the global population. Rigorous R&D activities to develop new drugs and therapies are also likely to augur the growth of the market over the forecast period. Unhealthy diet and a sedentary lifestyle can also be considered as a major reason for the growth of the global dyspepsia market. Due to the current busy lifestyle, consumers are more prone to consuming on-the-go food items which are generally unhealthy and cause digestive disorders. Additionally, such a situation is worsened by smoking and alcohol consumption which favors market growth. On the flipside, the growth of the market might be hindered by high costs associated with diagnostic tests and cut-throat competition among market players.

Competitive Landscape

The notable players in the global dyspepsia market include Allergan Plc, Takeda Pharmaceutical Company, Abbott Laboratories, Johnson & Johnson, Eisai Co., Ltd., Sanofi, Bayer AG, Salix Pharmaceuticals, AstraZeneca, Boehringer Ingelheim GmbH, and GlaxoSmithKline.

Segmentation

The global dyspepsia market has been segmented based on diagnosis, treatment, and end user.

By diagnosis, the global dyspepsia market has been segmented into blood tests, breath tests, stool tests, endoscopy, X-ray, CT scan, and others.

By treatment, the global dyspepsia market has been segmented into antacids, antibiotics, h2 blockers, proton pump inhibitors (PPIs), prokinetics, psychological therapies, and others. The antacids segment has been further segmented into calcium carbonate, loperamide, simethicone, sodium bicarbonate, and others. The antibiotic segment has been further segmented into amoxicillin, clarithromycin, metronidazole, and others.  The H2 blockers segment has been further segmented into cimetidine, famotidine, nizatidine, ranitidine, and others. The Proton pump inhibitors (PPIs) segment has been further segmented into esomeprazole, lansoprazole, and omeprazole. Prokinetics are categorized into bethanechol and metoclopramide.

By end user, the global dyspepsia market has been segmented into hospitals and clinics, ambulatory surgical centers, pharmacies, diagnostic centers, and others.

Regional Analysis

By region, the global dyspepsia market has been segmented into the Americas, Europe, Asia-Pacific (APAC), and the Middle East and Africa (MEA).

Browse Complete Premium Research Report @ https://www.marketresearchfuture.com/reports/dyspepsia-market-6351

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

…TOC Continued!

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/6351     

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/dyspepsia-market-6351